A missense mutation in a patient with developmental delay affects the activity and structure of the hexosamine biosynthetic pathway enzyme AGX1.
FEBS Lett. 2021 Jan;595(1):110-122. doi: 10.1002/1873-3468.13968. Epub 2020 Nov 18.
FEBS Lett. 2021.
PMID: 33098688
Free PMC article.